Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study

NCT06890871 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ENROLLING_BY_INVITATION

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer, Metastatic Breast Cancer

Interventions

RADIATION: Intensity-modulated radiotherapy
DRUG: Immunotherapy Therapy

Sponsor

Zhongnan Hospital